Formycon AG Sustainability Reports
Formycon AG is an independent biotechnology company specializing in the development of high-quality biosimilars and follow-on biopharmaceutical medicines.
Sector: Professional & technical services
Country: Germany
Exchange: Deutsche Börse (Xetra)
LEI: 39120005TZ76GQOY8Z19
FIGI: BBG001TCVMH8
12 reports from 2015 to 2025
